Bioequivalence study of azilsartan medoxomil 80 mg tablets vs Edarbi
Part of Heart & circulation clinical trials.
This study tests whether a new generic version of the blood pressure medication azilsartan medoxomil works the same as the brand-name drug Edarbi in healthy volunteers. It involves taking two different tablet formulations and checking how your body absorbs them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- You must be a non-smoker (no nicotine for at least 6 months).
- Your body mass index (BMI) must be between 18.5 and 30 kg/m2, and you must weigh at least 50 kg but no more than 120 kg.
- You must be generally healthy as confirmed by medical exams, blood tests, and heart monitoring.
- You must agree to use reliable birth control (if applicable) during the study and for a period after.
- You must be willing to follow strict dietary and lifestyle restrictions (e.g., no alcohol, caffeine, grapefruit).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how two investigational drugs interact when taken together in healthy adults. It looks at safety and how the drugs move through the body.
This study tests a blood pressure medication (an angiotensin receptor-neprilysin inhibitor, or ARNi) in adults with high blood pressure in the United Arab Emirates. It looks at how well the medicine works in real life, and may be an option if you are just starting treatment or already taking one blood pressure pill.
This trial tests how the body processes the blood pressure medication Allisartan Isoproxil. It is for healthy adults who want to help researchers understand the drug's effects.
This study compares how two different tablet versions of a combination of vicadrostat and empagliflozin are absorbed by the body. It is for healthy volunteers to see which form works better.
This study tests whether a generic version of the cholesterol-lowering drug fluvastatin works the same as the brand-name version. Healthy volunteers take both versions to compare how the body absorbs them.
This study compares a new version of the blood-thinning drug enoxaparin (called a biosimilar) to the standard brand, Clexane. If you are a healthy adult, you might be eligible to participate, which helps ensure the new drug works the same way.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.